Plasmid vector of human TP53, 240N mutant.
Clone info. | Plasmid vector of human TP53, S240N mutant. |
---|---|
Vector backbone | pDONR221 (Plasmid) |
Selectable markers | Kan^r (E. coli) |
Gene/insert name | Human TP53 cDNA |
Depositor|Developer | DNA Bank, | Murata, Takehide | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
Remarks | Gateway® Entry clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 |
備考 | Gateway®テクノロジーを用いたエントリークローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07045 | pENTR-hsTP53 S240N | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pENTR-hsTP53 S240N was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07045). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07045_A7Kap1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB07045_A7Kaa.seq ![]() |
---|
>07045_07045_A7Ka_1_M13_-40_D01_04_ABI08.ab1 1 AGGCCCGGCC TTTAAGCTCG GGGCCCAAAT AATGATTTTA TTTTGACTGA TAGTGACCTG 61 TTCGTTGCAA CAAATTGATG AGCAATGCTT TTTTATAATG CCAACTTTGT ACAAAAAAGC 121 AGGCTCGGAG GAGCCGCAGT CAGATCCTAG CGTCGAGCCC CCTCTGAGTC AGGAAACATT 181 TTCAGACCTA TGGAAACTAC TTCCTGAAAA CAACGTTCTG TCCCCCTTGC CGTCCCAAGC 241 AATGGATGAT TTGATGCTGT CCCCGGACGA TATTGAACAA TGGTTCACTG AAGACCCAGG 301 TCCAGATGAA GCTCCCAGAA TGCCAGAGGC TGCTCCCCCC GTGGCCCCTG CACCAGCAGC 361 TCCTACACCG GCGGCCCCTG CACCAGCCCC CTCCTGGCCC CTGTCATCTT CTGTCCCTTC 421 CCAGAAAACC TACCAGGGCA GCTACGGTTT CCGTCTGGGC TTCTTGCATT CTGGGACAGC 481 CAAGTCTGTG ACTTGCACGT ACTCCCCTGC CCTCAACAAG ATGTTTTGCC AACTGGCCAA 541 GACCTGCCCT GTGCAGCTGT GGGTTGATTC CACACCCCCG CCCGGCACCC GCGTCCGCGC 601 CATGGCCATC TACAAGCAGT CACAGCACAT GACGGAGGTT GTGAGGCGCT GCCCCCACCA 661 TGAGCGCTGC TCAGATAGCG ATGGTCTGGC CCCTCCTCAG CATCTTATCC GAGTGGAAGG 721 AAATTTGCGT GTGGAGTATT TGGATGACAG AAACACTTTT CGACATAGTG TGGTGGTGCC 781 CTATGAGCCG CCTGAGGTTG GCTCTGACTG TACCACCATC CACTACAACT ACATGTGTAA 841 CAATTCCTGC ATGGGCGGCA TGAACCGGAG GCCCATCCTC ACCATCATCA CACTGGAAGA 901 CTCCAGTGGT AATCTACTGG GACGGAACAG CTTTGAGGTG CGTGTTTGTG CCTGTCCTGG 961 GAGAGACCGG CGCACAGAGG AAGAGAATCT CCCGCAAGAA AGGGGAGCCT CACCACGAGC 1021 TGCCCCTCAG GAGCACTAAG CGAGCACTGC TCAACAACAC CAGCTCCTCC TCCCCCAGCC 1081 CAAAGAGAAA CCACTGGATT GGAGAATATT TCAACCCTTC AGATCGTGGG CCGTTGAGCG 1141 CTTTCGTAGA AATTGTTTCT CCGGAGAGAA GCC // |
Primer: M13R Sequence file: RDB07045_A7Kab.seq ![]() |
>07045_07045_A7Ka_1_M13R_E01_05_ABI08.ab1 1 ACCAAAAAAG GGGGGAATCA GCTGGATGGC AATAATGATT TTATTTTGAC TGATAGTGAC 61 CTGTTCGTTG CAACAAATTG AAAAGCAATG CTTTCTTATA ATGCCAACTT TGTACAAGAA 121 AGCTGGGTTC AGTCTGAGTC AGGCCCTTCT GTCTTGAACA TGAGTTTTTT ATGGCGGGAG 181 GTAGACTGAC CCTTTTTGGA CTTCAGGTGG CTGGAGTGAG CCCTGCTCCC CCCTGGCTCC 241 TTCCCAGCCT GGGCATCCTT GAGTTCCAAG GCCTCATTCA GCTCTCGGAA CATCTCGAAG 301 CGCTCACGCC CACGGATCTG AAGGGTGAAA TATTCTCCAT CCAGTGGTTT CTTCTTTGGC 361 TGGGGAGAGG AGCTGGTGTT GTTGGGCAGT GCTCGCTTAG TGCTCCCTGG GGGCAGCTCG 421 TGGTGAGGCT CCCCTTTCTT GCGGAGATTC TCTTCCTCTG TGCGCCGGTC TCTCCCAGGA 481 CAGGCACAAA CACGCACCTC AAAGCTGTTC CGTCCCAGTA GATTACCACT GGAGTCTTCC 541 AGTGTGATGA TGGTGAGGAT GGGCCTCCGG TTCATGCCGC CCATGCAGGA ATTGTTACAC 601 ATGTAGTTGT AGTGGATGGT GGTACAGTCA GAGCCAACCT CAGGCGGCTC ATAGGGCACC 661 ACCACACTAT GTCGAAAAGT GTTTCTGTCA TCCAAATACT CCACACGCAA ATTTCCTTCC 721 ACTCGGATAA GATGCTGAGG AGGGGCCAGA CCATCGCTAT CTGAGCAGCG CTCATGGTGG 781 GGGCAGCGCC TCACAACCTC CGTCATGTGC TGTGACTGCT TGTAGATGGC CATGGCGCGG 841 ACGCGGGTGC CGGGCGGGGG TGTGGAATCA ACCCACAGCT GCACAGGGCA GGTCTTGGCC 901 AGTTGGCAAA ACATCTTGTT GAGGGCAGGG GAGTACGTGC AAGTCACAGA CTTGGCTGTC 961 CCAGAATGCA AGAAGCCCAG ACGGGAAACC GTAGCTGCCC TGGTAGGTTT TCTGGAAGGG 1021 ACAGAAGATG ACAGGGGCCA GAGGGGGCTG GGTGCAGGGC CCGCCGTGTA AGAGCTGCTG 1081 GTGCAGGGGC CACGGAGGGA AGCAGCCTCT ACATTTCTGG GGAGCTTCAA TCTTGGGAAC 1141 CCTGGGG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content